Form 8-K - Current report:
SEC Accession No. 0001213900-24-112515
Filing Date
2024-12-26
Accepted
2024-12-26 11:49:25
Documents
16
Period of Report
2024-12-18
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 3.02: Unregistered Sales of Equity Securities
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea0225907-8k_bespoke.htm   iXBRL 8-K 26899
2 FORM OF PURCHASE AGREEMENT ea022590701ex10-1_bespoke.htm EX-10.1 50710
3 FORM OF NOTE ea022590701ex10-2_bespoke.htm EX-10.2 26212
4 FORM OF WARRANT ea022590701ex10-3_bespoke.htm EX-10.3 26348
  Complete submission text file 0001213900-24-112515.txt   330269

Data Files

Seq Description Document Type Size
5 XBRL SCHEMA FILE bspk-20241218.xsd EX-101.SCH 3036
6 XBRL LABEL FILE bspk-20241218_lab.xml EX-101.LAB 34240
7 XBRL PRESENTATION FILE bspk-20241218_pre.xml EX-101.PRE 22373
18 EXTRACTED XBRL INSTANCE DOCUMENT ea0225907-8k_bespoke_htm.xml XML 3345
Mailing Address 12001 E. 33RD ST- UNIT O AURORA CO 80010
Business Address 12001 E. 33RD ST- UNIT O AURORA CO 80010 720-949-1143
Bespoke Extracts, Inc. (Filer) CIK: 0001409197 (see all company filings)

EIN.: 204743354 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-52759 | Film No.: 241579520
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)